Apnimed, Inc. (APMD) vs Corvus Pharmaceuticals, Inc. (CRVS)
A side-by-side comparison of Apnimed, Inc. and Corvus Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APMD
Apnimed, Inc.
$21.94HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CRVS
Corvus Pharmaceuticals, Inc.
$10.74HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — APMD vs CRVS
growth of $100 · dividends reinvested · last 1yAPMD +35.9% (+35.9%/yr)CRVS -17.6% (-17.6%/yr)APMD compounded faster over this window
APMD CRVS
Metrics side by side
Total return (annualized)
| Metric | APMD | CRVS |
|---|---|---|
| Total return (1Y) | N/A | 49.09% |
| Total return CAGR (3Y) | N/A | 93.14% |
| Total return CAGR (5Y) | N/A | 17.88% |
| Total return CAGR (10Y) | N/A | -4.26% |
APMD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.